Cite
van Veldhoven K, Polidoro S, Baglietto L, et al. Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis. Clin Epigenetics. 2015;7:67doi: 10.1186/s13148-015-0104-2.
van Veldhoven, K., Polidoro, S., Baglietto, L., Severi, G., Sacerdote, C., Panico, S., Mattiello, A., Palli, D., Masala, G., Krogh, V., Agnoli, C., Tumino, R., Frasca, G., Flower, K., Curry, E., Orr, N., Tomczyk, K., Jones, M. E., Ashworth, A., Swerdlow, A., Chadeau-Hyam, M., Lund, E., Garcia-Closas, M., Sandanger, T. M., Flanagan, J. M., & Vineis, P. (2015). Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis. Clinical epigenetics, 767. https://doi.org/10.1186/s13148-015-0104-2
van Veldhoven, Karin, et al. "Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis." Clinical epigenetics vol. 7 (2015): 67. doi: https://doi.org/10.1186/s13148-015-0104-2
van Veldhoven K, Polidoro S, Baglietto L, Severi G, Sacerdote C, Panico S, Mattiello A, Palli D, Masala G, Krogh V, Agnoli C, Tumino R, Frasca G, Flower K, Curry E, Orr N, Tomczyk K, Jones ME, Ashworth A, Swerdlow A, Chadeau-Hyam M, Lund E, Garcia-Closas M, Sandanger TM, Flanagan JM, Vineis P. Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis. Clin Epigenetics. 2015 Aug 04;7:67. doi: 10.1186/s13148-015-0104-2. eCollection 2015. PMID: 26244061; PMCID: PMC4524428.
Copy
Download .nbib